His primary areas of investigation include Immunology, Internal medicine, Inflammatory bowel disease, Crohn's disease and Gastroenterology. While the research belongs to areas of Immunology, Matthieu Allez spends his time largely on the problem of Cell biology, intersecting his research to questions surrounding Interleukin-7 receptor and Interleukin 13. In his research, Colectomy is intimately related to Surgery, which falls under the overarching field of Internal medicine.
His Inflammatory bowel disease study combines topics from a wide range of disciplines, such as Antigen and Ulcerative colitis. The various areas that he examines in his Crohn's disease study include Infliximab and Retrospective cohort study. His Gastroenterology research is multidisciplinary, incorporating perspectives in Discontinuation, Adverse effect, Primary sclerosing cholangitis, Prospective cohort study and C-reactive protein.
Internal medicine, Crohn's disease, Gastroenterology, Inflammatory bowel disease and Immunology are his primary areas of study. In the field of Internal medicine, his study on Ulcerative colitis, Infliximab, Disease and Retrospective cohort study overlaps with subjects such as In patient. His studies deal with areas such as Prospective cohort study, Surgery, Refractory, Adverse effect and Cohort as well as Crohn's disease.
His biological study spans a wide range of topics, including Colectomy, Primary sclerosing cholangitis, Incidence and Endoscopy. The study incorporates disciplines such as Rheumatoid arthritis and Intensive care medicine in addition to Inflammatory bowel disease. His research ties NKG2D and Immunology together.
Matthieu Allez mainly focuses on Internal medicine, Crohn's disease, Inflammatory bowel disease, Ulcerative colitis and Gastroenterology. His Crohn's disease study incorporates themes from Cumulative incidence and Surgery, Endoscopy, Transplantation. He interconnects Irritable bowel syndrome, Disease severity, Immunology and Intensive care medicine in the investigation of issues within Inflammatory bowel disease.
His Immunology research integrates issues from Hematopoietic stem cell transplantation and Stem cell. His studies in Ulcerative colitis integrate themes in fields like Cross-sectional study, Colitis and Hazard ratio. Matthieu Allez has researched Gastroenterology in several fields, including Pouch, Area under the curve, Interquartile range, Incidence and Refractory.
Matthieu Allez mostly deals with Crohn's disease, Internal medicine, Disease, Inflammatory bowel disease and Immune system. His study in Crohn's disease is interdisciplinary in nature, drawing from both Gastroenterology, Odds ratio, Pathogenesis and Enthesitis. His study in the field of Autoimmune enteropathy also crosses realms of Ruxolitinib.
His Inflammatory bowel disease research incorporates elements of Inflammation, Concomitant, Transmission and Intensive care medicine. His Immune system study integrates concerns from other disciplines, such as Cell, Antibody and NKG2D. His study explores the link between Cohort and topics such as Metabolite that cross with problems in Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
CEACAM6 acts as a receptor for adherent-invasive E. coli , supporting ileal mucosa colonization in Crohn disease
Nicolas Barnich;Frédéric A. Carvalho;Anne-Lise Glasser;Claude Darcha.
Journal of Clinical Investigation (2007)
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Andreas Acs.
European Journal of Immunology (2019)
The First European Evidence-Based Consensus on Extra-Intestinal Manifestations in Inflammatory Bowel Disease
Marcus Harbord;Vito Annese;Stephan R. Vavricka;Matthieu Allez.
Journal of Crohns & Colitis (2016)
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
David Laharie;Arnaud Bourreille;Julien Branche;Matthieu Allez.
The Lancet (2012)
Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I With Type II
Georgia Malamut;Pauline Afchain;Virginie Verkarre;Thierry Lecomte.
Incidence of Autoimmune Diseases in Celiac Disease: Protective Effect of the Gluten-Free Diet
Jacques Cosnes;Christophe Cellier;Sheila Viola;Jean–Frederic Colombel.
Clinical Gastroenterology and Hepatology (2008)
Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation.
Ai Ing Lim;Ai Ing Lim;Ai Ing Lim;Yan Li;Yan Li;Silvia Lopez-Lastra;Silvia Lopez-Lastra;Silvia Lopez-Lastra;Ralph Stadhouders.
Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease
Pierre Desreumaux;Arnaud Foussat;Matthieu Allez;Laurent Beaugerie.
Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy.
Matthieu Allez;Marc Lemann;Joëlle Bonnet;Pierre Cattan.
The American Journal of Gastroenterology (2002)
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects.
Matthieu Allez;Matthieu Allez;Konstantinos Karmiris;Edouard Louis;Gert Van Assche.
Journal of Crohn's and Colitis (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: